Removing coverage for gender-affirming care could have devastating consequences for this vulnerable population. Many trans individuals already face…
Eli Lilly (NYSE: LLY) has been experiencing significant growth in sales, largely attributed to the success of Zepbound,…
Week four of the NWSL regular season saw some incredible performances from players across the league, and Attacking…
Eli Lilly's move to offer lower-priced vials of its obesity drug Zepbound was seen as a step towards…
The United Kingdom is set to introduce Eli Lilly's weight loss drug, Mounjaro, next year in an effort…
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.…
Sign in to your account